Seven small-molecule anti-coronavirus drugs are currently in clinical research, renowned Chinese respiratory expert Zhong Nanshan said.
Researchers have found that ACE2, a type of enzyme receptor for the SARS coronavirus (SARS-CoV), also plays a key role in the 2019-nCoV's interaction with human cells.
"We have developed some effective treatment plans based on successful experience and practices from fighting against SARS. The use of multiple life support measures has increased the success rate of treatment," Xinhua cited Zhong as saying.
According to Zhong, more clinical evidence is needed to prove the effect of drugs used in some individual cases and it takes time for the vaccine against the virus not yet developed to go into clinical application.
![November 2025 in photos: New Year at GUM, the "City of Living Stories," and autumn scenes](https://en.vestikavkaza.ru/upload2/s400xfull/2025-12-02/1764706769692f49d1538777.83780174.webp "November 2025 in photos: New Year at GUM, the "City of Living Stories," and autumn scenes")
